{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Sofosbuvir%2FVelpatasvir", "query": { "intervention": "Sofosbuvir/Velpatasvir" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 66, "total_pages": 7, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Sofosbuvir%2FVelpatasvir&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-27T02:15:11.951Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04075916", "title": "A Trial of Transplanting Hepatitis C Kidneys Into Hepatitis C-Negative Kidney Recipients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "End Stage Renal Disease" ], "interventions": [ { "name": "Epclusa", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 201, "start_date": "2021-06-22", "completion_date": "2026-02-25", "has_results": false, "last_update_posted_date": "2026-03-12", "last_synced_at": "2026-09-27T02:15:11.951Z", "location_count": 11, "location_summary": "Birmingham, Alabama • Gainesville, Florida • Miami, Florida + 8 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04075916" }, { "nct_id": "NCT02938013", "title": "deLIVER: Direct Acting Antiviral Effects on the Liver", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "HCV Coinfection", "Liver Disease", "HIV" ], "interventions": [ { "name": "Sofosbuvir/Velpatasvir/Voxilaprevir [SOF/VEL/VOX]", "type": "DRUG" }, { "name": "Sofosbuvir/Velpatasvir (SOF/VEL)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 15, "start_date": "2017-01", "completion_date": "2020-09-30", "has_results": true, "last_update_posted_date": "2022-02-24", "last_synced_at": "2026-09-27T02:15:11.951Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02938013" }, { "nct_id": "NCT02346721", "title": "Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hepatitis C Virus Infection" ], "interventions": [ { "name": "SOF/VEL", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 111, "start_date": "2015-02-23", "completion_date": "2016-06-15", "has_results": true, "last_update_posted_date": "2018-11-16", "last_synced_at": "2026-09-27T02:15:11.951Z", "location_count": 25, "location_summary": "Long Beach, California • Los Angeles, California • Palo Alto, California + 18 more", "locations": [ { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02346721" }, { "nct_id": "NCT01457755", "title": "Gilead Sustained Virologic Response (SVR) Registry", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hepatitis C, Chronic" ], "interventions": [], "intervention_types": [], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 6625, "start_date": "2012-04-13", "completion_date": "2018-01-08", "has_results": false, "last_update_posted_date": "2018-08-31", "last_synced_at": "2026-09-27T02:15:11.951Z", "location_count": 162, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Phoenix, Arizona + 102 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01457755" }, { "nct_id": "NCT02639338", "title": "Safety and Efficacy of SOF/VEL/VOX FDC for 8 Weeks and SOF/VEL for 12 Weeks in Adults Chronic Genotype 3 HCV Infection and Cirrhosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hepatitis C Virus Infection" ], "interventions": [ { "name": "SOF/VEL/VOX", "type": "DRUG" }, { "name": "SOF/VEL", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 220, "start_date": "2015-12-23", "completion_date": "2017-01-02", "has_results": true, "last_update_posted_date": "2019-03-05", "last_synced_at": "2026-09-27T02:15:11.951Z", "location_count": 30, "location_summary": "Long Beach, California • Los Angeles, California • Palo Alto, California + 27 more", "locations": [ { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Rialto", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02639338" }, { "nct_id": "NCT03949764", "title": "The Kentucky Viral Hepatitis Treatment Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hepatitis C", "Opioid-Related Disorders", "Injection Drug Use" ], "interventions": [ { "name": "Sofosbuvir/velpatasvir (Epclusa®)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Jennifer Havens", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 374, "start_date": "2019-09-23", "completion_date": "2025-06-30", "has_results": false, "last_update_posted_date": "2025-08-06", "last_synced_at": "2026-09-27T02:15:11.951Z", "location_count": 1, "location_summary": "Hazard, Kentucky", "locations": [ { "city": "Hazard", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT03949764" }, { "nct_id": "NCT02201901", "title": "Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection and Child-Pugh Class B Cirrhosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hepatitis C Virus Infection" ], "interventions": [ { "name": "SOF/VEL", "type": "DRUG" }, { "name": "RBV", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 268, "start_date": "2014-07", "completion_date": "2015-11", "has_results": true, "last_update_posted_date": "2018-11-15", "last_synced_at": "2026-09-27T02:15:11.951Z", "location_count": 49, "location_summary": "Phoenix, Arizona • La Jolla, California • Los Angeles, California + 40 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Pasadena", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02201901" }, { "nct_id": "NCT03619837", "title": "Prevention of De Novo HCV With Antiviral HCV Therapy Post-Liver and Post-Kidney Transplant", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hepatitis C", "Transplantation Disease Transmission" ], "interventions": [ { "name": "Sofosbuvir/Velpatasvir", "type": "DRUG" }, { "name": "Sofosbuvir/Velpatasvir/Voxilaprevir", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 122, "start_date": "2018-07-15", "completion_date": "2020-08-13", "has_results": true, "last_update_posted_date": "2021-03-03", "last_synced_at": "2026-09-27T02:15:11.951Z", "location_count": 6, "location_summary": "San Francisco, California • Aurora, Colorado • Atlanta, Georgia + 3 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "New York", "state": "New York" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03619837" }, { "nct_id": "NCT03627546", "title": "HCV Seek, Test and Rapid Treatment for Young PWID", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hepatitis C", "Drug Use" ], "interventions": [ { "name": "Rapid Treatment strategy", "type": "OTHER" }, { "name": "Usual Care (facilitated referral)", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Weill Medical College of Cornell University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "29 Years", "sex": "ALL", "summary": "18 Years to 29 Years" }, "enrollment_count": 39, "start_date": "2018-09-18", "completion_date": "2021-06-30", "has_results": true, "last_update_posted_date": "2024-04-29", "last_synced_at": "2026-09-27T02:15:11.951Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03627546" }, { "nct_id": "NCT02300103", "title": "Efficacy And Safety Of Sofosbuvir/Velpatasvir Fixed Dose Combination With Ribavirin in Chronic HCV Infected Adults Who Participated in a Prior Gilead Sponsored HCV Treatment Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hepatitis C Virus Infection" ], "interventions": [ { "name": "SOF/VEL", "type": "DRUG" }, { "name": "RBV", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 69, "start_date": "2014-12-01", "completion_date": "2016-09-15", "has_results": true, "last_update_posted_date": "2018-11-16", "last_synced_at": "2026-09-27T02:15:11.951Z", "location_count": 23, "location_summary": "San Diego, California • San Marcos, California • Aurora, Colorado + 20 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "San Marcos", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02300103" } ] }